ÂÜÀòÂÒÂ×

Roger Stoll currently serves as the Executive Chairman of Delcath Systems, Inc., a position held since September 2015. Stoll has extensive experience in the pharmaceutical industry, having held various leadership roles, including Director on the Board of Chelsea Therapeutics and its international subsidiary from 2008 to 2010, and their involvement on the Board of Directors for Cortex Pharmaceuticals from 2003 to 2010. Previously, Stoll was the Chief Executive Officer at Questcor Pharmaceuticals from 1999 to 2004 and served in executive capacities at Ohmeda and The BOC Group from 1991 to 1999. Stoll's academic credentials include a Post-Doctoral Studies in Pharmacokinetics at the University of Michigan, a Ph.D. in Biopharmaceutics/Pharmacokinetics from the University of Connecticut, and a Bachelor of Pharmacy from Ferris State University.